-+ 0.00%
-+ 0.00%
-+ 0.00%

Atossa Therapeutics CEO Steven Quay joins ARDD 2026 panel on clinical trials, regulatory pathways for aging diseases

PUBT·09/24/2026 12:01:39
Listen to the news
Atossa Therapeutics CEO Steven Quay joins ARDD 2026 panel on clinical trials, regulatory pathways for aging diseases
  • Atossa Therapeutics CEO Steven Quay will speak at ARDD 2026 at Harvard University in Boston on Oct. 1, 2026.
  • Quay is slated for an 11:20 a.m.–12:00 p.m. ET panel on clinical trials and regulatory pathways for diseases of aging.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atossa Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202609240800PR_NEWS_USPR_____SF54668) on September 24, 2026, and is solely responsible for the information contained therein.